Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $0.09.

  • Cryo Cell International's EPS (Basic) fell 3076.92% to $0.09 in Q3 2025 from the same period last year, while for Aug 2025 it was -$0.07, marking a year-over-year increase of 9339.62%. This contributed to the annual value of $0.05 for FY2024, which is 10438.6% up from last year.
  • Per Cryo Cell International's latest filing, its EPS (Basic) stood at $0.09 for Q3 2025, which was down 3076.92% from $0.04 recorded in Q2 2025.
  • In the past 5 years, Cryo Cell International's EPS (Basic) registered a high of $0.15 during Q2 2021, and its lowest value of -$1.34 during Q4 2023.
  • Its 5-year average for EPS (Basic) is -$0.02, with a median of $0.08 in 2022.
  • Per our database at Business Quant, Cryo Cell International's EPS (Basic) surged by 22500.0% in 2022 and then plummeted by 144000.0% in 2023.
  • Cryo Cell International's EPS (Basic) (Quarter) stood at -$0.08 in 2021, then skyrocketed by 225.0% to $0.1 in 2022, then crashed by 1440.0% to -$1.34 in 2023, then surged by 82.84% to -$0.23 in 2024, then surged by 139.13% to $0.09 in 2025.
  • Its EPS (Basic) stands at $0.09 for Q3 2025, versus $0.04 for Q2 2025 and $0.03 for Q1 2025.